Fuji H, Milgrom F
J Exp Med. 1973 Jul 1;138(1):16-32. doi: 10.1084/jem.138.1.16.
In vitro cultures of spleen cells (S) from normal 8-10-wk-old DBA/2J mice were shown to develop a small number of plaque-forming cells (PFC) that released antibodies lytic to syngenic and autologous thymus cells as well as to syngenic lymphoma L5178Y cells used as the target in the PFC assay. A marked increase in the number of PFC detectable on L5178Y target cells was demonstrated on day 4 in the cultures of S cells to which syngenic or autologous thymus cells had been added (S+T) at time 0, whereas the PFC detectable on thymus cells in such cultures remained at a level similar to that in S cultures. This suggested that two populations of PFC participated in the observed phenomena. No PFC developed in the culture of thymus cells (T). The addition of the cell-free supernatants of 24-h cultures of T or of L5178Y cells to syngenic S cultures also caused a specific increase in the number of the PFC detectable on L5178Y, which suggested that certain immunogenic factors released from the T cells stimulated the response observed in the S+T cultures. Antibodies of IgM nature were detected in the supernatants of S+T cultures by means of cytolysis in agar of L5178Y cells. Although such antibodies did not cause lysis of thymus cells, they could be completely removed by absorption with normal adult or fetal thymus cells of syngenic origin. Still, the absorbing capacity of L5178Y was much higher than that of thymus cells. The absorption was more efficient at 4 degrees C than at 22 degrees C, and hardly any absorption occurred at 37 degrees C. The tissue distribution of the antigen under study seemed to be restricted to thymus cells since no other murine tissue cells tested removed the antibodies. The thymic antigen under study was not restricted to strain DBA/2J and could be demonstrated on thymus cells of all other strains tested. On the other hand, the ability of spleen cells to respond in vitro to this antigen has thus far been observed only in DBA/2J mice. Spleen cells of strains C57BL/6J and NZB/BINJ as well as (DBA/2 x NZB)F(1) failed to show any significant increase in the PFC response detectable on the L5178Y target when syngenic thymus cells or DBA/2J thymus cells were added. An intravenous injection of syngenic thymus cells to DBA/2J mice also caused the appearance in their spleens of PFC detectable on the L5178Y target. The described in vitro system may provide a good means of studying the cellular basis of generation of self-tolerance and of its breakdown.
研究表明,来自8 - 10周龄正常DBA/2J小鼠的脾细胞(S)体外培养物中会产生少量噬斑形成细胞(PFC),这些细胞释放的抗体可溶解同基因和自体胸腺细胞以及用作PFC检测靶标的同基因淋巴瘤L5178Y细胞。在0时刻添加了同基因或自体胸腺细胞的S细胞培养物(S + T)中,第4天在L5178Y靶细胞上可检测到的PFC数量显著增加,而在此类培养物中胸腺细胞上可检测到的PFC数量保持在与S培养物中相似的水平。这表明有两类PFC参与了所观察到的现象。胸腺细胞(T)培养物中未产生PFC。将T细胞或L5178Y细胞24小时培养物的无细胞上清液添加到同基因S培养物中,也导致在L5178Y上可检测到的PFC数量特异性增加,这表明T细胞释放的某些免疫原性因子刺激了S + T培养物中观察到的反应。通过L5178Y细胞的琼脂溶细胞法在S + T培养物的上清液中检测到了IgM性质的抗体。尽管此类抗体不会导致胸腺细胞溶解,但它们可被同基因来源的正常成年或胎儿胸腺细胞吸收而完全去除。不过,L5178Y的吸收能力比胸腺细胞高得多。4℃时的吸收比22℃时更有效,37℃时几乎不发生吸收。所研究抗原的组织分布似乎仅限于胸腺细胞,因为测试的其他小鼠组织细胞均不能去除这些抗体。所研究的胸腺抗原不限于DBA/2J品系,在所有测试的其他品系的胸腺细胞上均可检测到。另一方面,迄今为止仅在DBA/2J小鼠中观察到脾细胞体外对该抗原产生反应的能力。当添加同基因胸腺细胞或DBA/2J胸腺细胞时,C57BL/6J和NZB/BINJ品系以及(DBA/2×NZB)F1的脾细胞在L5178Y靶标上可检测到的PFC反应未显示出任何显著增加。给DBA/2J小鼠静脉注射同基因胸腺细胞也导致其脾脏中出现可在L5178Y靶标上检测到的PFC。所描述的体外系统可能为研究自身耐受性产生及其破坏的细胞基础提供一个良好的手段。